Expand All | Collapse All
Rudolph A. Rodriguez, MD, Chair
Dr. Rodriguez, a board-certified internist and nephrologist, is the Director of the Hospital & Specialty Medicine Service Line at the VA Puget Sound Health Care System and a Professor and Vice Chair of the Department of Medicine at the University of Washington. As a clinician scholar, his academic career focused on nephrology fellowship education along with scholarly work on issues related to vulnerable populations.
Dr. Rodriguez serves as a member of the American Board of Internal Medicine Nephrology Board. He is the Chair of the Veteran Affairs Nephrology Field Advisory Committee. He served on the American Society of Nephrology Training Program Director’s Executive Committee.
Dr. Rodriguez attended Stanford University and earned his medical degree at the Charles Drew/UCLA Medical Education Program at the University of California, Los Angeles. He completed his internal medicine residency at California Pacific Medical Center, and his nephrology fellowship training at the University of California, San Francisco.
As of July 2019, Dr. Rodriguez reported the following external relationships:
Work as an author or editor for the following company, with compensation as listed:
- UpToDate, receiving compensation for authorship.
Dr. Rodriguez serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Veterans Affairs, serving as Chair, of the Field Advisory Committee, without compensation.
Deborah B. Adey, MD
Dr. Adey is a transplant nephrologist at the University of California, San Francisco (UCSF) and the Medical Director of the Kidney Transplant program at UCSF. She had the honor of participating in all aspects of transplant nephrology from donor evaluations, pre-transplant evaluations, in-hospital care, and post-transplant follow-up. She has been the site fellowship director for general nephrology at UCSF for a few years, then started the transplant nephrology fellowship program at UCSF which she ran for seven years. Dr. Adey initially became board certified in Internal Medicine and Nephrology in 1996, and1996 and was recertified in 2006 and again in 2016 in both Internal Medicine and Nephrology.
On a national level, she has been the chair of the Transplant Nephrology Accreditation Program for the American Society of Transplantation (AST) and subsequently the Chair of the board of managers for the Transplant Nephrology Fellowship Accreditation Program, an LLC subsidiary of the AST. She serves as a member of the American Board of Internal Medicine Nephrology Board.
Dr. Adey initially became board certified in Internal Medicine and Nephrology in 1996, and was recertified in 2006 and again in 2016 in both Internal Medicine and Nephrology.
Dr. Adey received her medical degree from the University of Colorado Health Sciences Center. She completed her nephrology fellowships at the University of Vermont followed by another two years of nephrology at Mayo Clinic Rochester, where she completed her research in protein metabolism in chronic kidney disease and focused clinically on kidney transplantation. She did a post-doctoral year of transplant, as this was before the days of transplant nephrology fellowships.
As of May 2020, Dr. Adey reported the following external relationships:
Dr. Adey serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Transplantation, Board Member, receiving reimbursement for travel expenses.
Linda Awdishu, PharmD
Dr. Awdishu is Professor and Chair of Clinical Pharmacy and Director of Interprofessional Education and Simulation at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences.
She developed and currently practices in the Joint Commission certified UCSD Kidney Disease Program, a multidisciplinary clinic involving a nephrologist, pharmacist, social worker, dietitian and nurse providing care for patients with CKD stage 2-5. She serves as a member of the Internal Medicine Nephrology Board; she teaches in the third -year pharmacy curriculum chairing the therapeutics overseeing simulations for second and third year pharmacy students.
Dr. Awdishu is the recipient of numerous teaching awards from pharmacy students and residents as well as the UCSD Academic Senate Distinguished Teaching Award. Her research program involves pharmacokinetics and pharmacogenomics of drugs in kidney disease. She co-directed The International Drug Induced Renal Injury Consortium (DIRECT) in collaboration with The International Serious Adverse Event Consortium. The DIRECT study is investigating the genetic basis of serious drug induced renal injury, through a collaborative network comprised of leading clinical research centers from around the world. She is a co-investigator in the UAB-UCSD O'Brien Center for Acute Kidney Injury Research studying new novel biomarkers of acute kidney injury.
Dr. Awdishu completed her Bbachelor of Sscience degree in pharmacy from the University of Toronto and completed a masters of advanced studies in clinical research from the University of California, San Diego in 2007. She completed her doctor of pharmacy from the University of Colorado in 2008.
As of July 2019, Dr. Awdishu reported the following external relationships:
Developing continuing medical education with funding from the following companies, with honoraria:
- Postgraduate Healthcare Education
Dr. Awdishu serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- American Society of Nephrology, Programming Committee Member, receiving reimbursement for travel expenses.
Funding for salary support, paid to the University of California, San Diego, from the following not-for-profit healthcare-related organization:
- National Institutes of Health, for a University of Alabama, Birmingham-University of California, San Diego O'Brien Center Grant.
Paul T. Conway
Mr. Conway is President of the American Association of Kidney Patients, America's oldest and largest independent kidney patient advocacy organization. He has managed kidney disease for thirty-seven years, including nearly three years on dialysis as a kidney transplant recipient for the past twenty years. He was recently selected the National Institutes of Health (NIH) to serve as a Member of the External Evaluation Panel for the NIH Kidney Precision Medicine Project. In 2017, he was named by the US Food and Drug Administration as the Chair of the new FDA Patient Engagement and Advocacy Committee for medical devices. Mr. Conway is the recipient of a 2017 President's Medal from the American Society of Nephrology and serves as an inaugural Patient Voice Editor for the Clinical Journal of the American Society of Nephrology.
As a policy professional, he has served under four US presidents, three governors and in support of five presidential transitions. He served on the 2016-2017 Presidential Transition Team as the Team Lead for the U.S. Office of Personnel Management and has subsequently served as an appointed member on the 2017 and 2018 Presidential Rank Review Board, the body charged with evaluating and recommending top career government executives for performance recognition by the White House. Mr. Conway’s previous Federal posts have included Chief of Staff of the US Department of Labor for Secretary, Chief of Staff of the U.S. Office of Personnel Management, an agency Chief of Staff at the US Department of Homeland Security (DHS) and Special Assistant in the White House Office of National Drug Control Policy. For the Commonwealth of Virginia, he has served as the Deputy Secretary of Health and Human Resources, a member of the Board of Health Professions and on a special review team for state mental health system modernization.
Mr. Conway works extensively with Congressional leaders and officials across the Federal government and serves on multiple national boards including: The Kidney Health Initiative; the United Network for Organ Sharing Kidney Committee; the Center for Dialysis Innovation at the University of Washington; and is a member of the Federal legal and regulatory issue team for the Clinical Trials Transformation Initiative at Duke University. Currently, he is a member of the American Board of Internal Medicine Nephrology Board.
As of May 2018, Mr. Conway reported the following external relationships:
Work as an author or editor for following companies, with compensation as listed:
- Clinical Journal of the American Society of Nephrology, receiving compensation for role as Patient Voice Editor.
Mr. Conway serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Association of Kidney Patients, President and Member of Executive Committee, receiving reimbursement for travel expenses.
- Patient Access to Pain Relief Coalition, Chair of the Steering Committee, without compensation.
- Kidney Health Initiative, Member of Board of Directors, receiving reimbursement for travel expenses.
- Clinical Trial Transformation Initiative, Member of Regulatory Review Project Team, receiving honoraria.
- University of Washington, Center for Dialysis Innovation, Member of Patient Advisory Board, without compensation.
- Food and Drug Administration, Chair of Patient Engagement Advisory Committee.
- United Network for Organ Sharing, Member of Kidney Committee.
- National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, External Expert Evaluator for Kidney Precision Medicine Project.
Mr. Conway also reported serving on panels and as a faculty member for American Society for Nephrology Kidney Week.
Deidra C. Crews, MD
Dr. Crews is a board-certified nephrologist and Associate Professor of Medicine in the Division of Nephrology and Associate Vice Chair for Diversity and Inclusion of the Department of Medicine at Johns Hopkins University School of Medicine. She is jointly appointed in the Johns Hopkins School of Nursing and holds faculty appointments with the Welch Center for Prevention, Epidemiology and Clinical Research, the Hopkins Center to Eliminate Cardiovascular Health Disparities and the Hopkins Center on Aging and Health.
Dr. Crews serves on the American Society of Nephrology (ASN) Diversity and Inclusion Committee (Chair, effective 2018), the Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team, the Advisory Panel on Addressing Disparities of the Patient-Centered Outcomes Research Institute, and on the editorial boards of Clinical Journal of the American Society of Nephrology and Advances in Chronic Kidney Disease. She represents ASN on the American College of Physicians' Council of Subspecialty Societies and has previously served as Chair of the ASN Chronic Kidney Disease Advisory Group. Additionally, Dr. Crews is a member of the American Board of Internal Medicine Nephrology Board.
She has received several awards for her research work, including the President's Research Recognition Award of the Johns Hopkins Urban Health Institute and the Ernest Everett Just Award in Medical and Public Health Research on African American Health and Quality of Life from the College of Charleston and the Medical University of South Carolina. She is a member of the National Academy of Medicine’s (NAM) Emerging Leaders Forum and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. She is a member of Alpha Omega Alpha Honor Medical Society.
Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master's degree in clinical epidemiology at Johns Hopkins University.
As of May 2020, Dr. Crews reported the following external relationships:
Work as an author or editor for following company, with compensation as listed:
- American Society of Nephrology, receiving compensation as an editor for Kidney360.
Dr. Crews serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Nephrology, Chair of Diversity and Inclusion Committee, Member of the Executive Committee, and Member of Program Committee for ASN Kidney Week, receiving reimbursement for travel expenses.
- National Kidney Foundation of Delaware/Maryland, Board of Directors Member, without compensation.
- American College of Physicians, Council of Subspecialist Societies, without compensation.
- Yale-New Haven Hospital Center for Outcomes Research and Evaluation, receiving honoraria.
Receiving compensation from the following non-profit healthcare organizations:
- MITRE Corporation, for serving as a consultant for their monitoring and evaluation program of the CMS ESRD Quality Incentive Program and on the CMS Kidney Health Affinity Group, receiving honoraria and reimbursement for travel expenses.
- Cleveland Clinic Foundation, serving as a speaker, receiving honoraria and reimbursement for travel expenses.
- Virginia Tech Carilion School of Medicine, serving as a speaker, receiving honoraria and reimbursement for travel expenses.
- National Institutes of Health- National Institute of Diabetes and Digestive and Kidney Health, serving on study section, receiving honoraria and reimbursement for travel expenses.
John C. Lieske, MD
Dr. Lieske is Professor of Medicine at the Mayo Clinic College of Medicine, and the Director of the Renal Function Laboratory in the Department of Laboratory Medicine and Pathology. He is also currently Principal Investigator for the Mayo Clinic O’Brien Urology Research Center, Assistant Director for the Rare Kidney Stone Consortium (Director of the Dent Disease component), and Principal Investigator for the Mayo NIH Nephrology Training Grant. He has a longstanding interest in urinary proteomics and nephrolithiasis, including NIH-funded projects to investigate inhibitors of crystal aggregation, growth, and adhesion to tubular cells; epidemiology of nephrolithiasis; genetics of nephrolithiasis; and mechanisms of enteric hyperoxaluria.
As director of the Renal Function Lab, Dr. Lieske has also developed expertise regarding renal markers of renal disease including tandem-MS based assays for urinary biomarkers and validation of newer markers of injury and kidney function (e.g., cystatin C, NGAL). Dr. Lieske previously conducted clinical trials regarding the role of diet and probiotics in patients with and without enteric hyperoxaluria. He has also studied the epidemiology of enteric hyperoxaluria and kidney disease after bariatric surgery. In Project 2 of the Mayo Clinic O’Brien Urology Research Center he is keenly interested in the biology or stone pathogenesis, including the role of the urinary microbiome.
Dr. Lieske received his bachelor’s degree in biomedical engineering from Northwestern University and his medical degree from the University of Chicago. He completed his residency and internship at Emory University and fellowships in clinical nephrology and research nephrology at the University of Chicago.
Funding for clinical trial expenses, staff, and salary support, paid to the Mayo Clinic, from the following companies:
- Allena, study of an oxalate-degrading enzyme in hyperoxaluric kidney stone formers.
- OxThera, for a trial of oxalobacter to treat primary hyperoxaluria.
- Siemens, for a clinical trial.
- Dicerna, for a clinical trial.
As of July 2019, Dr. Lieske reported the following external relationships:
- Alnylam, for a clinical trial on potential siRNA therapy for primary hyperoxaluria.
Attendance at investigators’ meetings, with compensation for travel expenses and honoraria from the following companies:
- Alnylam, participating in a study kick-off meeting, receiving reimbursement for travel expenses.
- Allena, participating in a study kick-off meeting, receiving reimbursement for travel expenses.
Service on a research-related expert panel or advisory board for the following companies, with honoraria:
Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities, paid to The Mayo Clinic, for the following company, with compensation as listed:
- OxThera, providing advice regarding trial design and interpretation for hyperoxaluria receiving research funding provided to the Mayo Clinic.
Dr. Lieske serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Oxalosis and Hyperoxaluria Foundation, member of Scientific Advisory Board, receiving reimbursement for travel expenses.
Samir K. Nangia, MD
Dr. Nangia, who is board certified in both Internal Medicine and Nephrology, is Chief of Staff at Methodist Mansfield Hospital and member of the Corporate Medical Board and ACO Board of Directors at Methodist Health System in Dallas,Texas. He is a practicing nephrologist with Dallas Renal Group and serves on the Board of Directors. He is also a Physician Development Coach at Texas Christian University/University of North Texas Health Science Center Medical School where he also serves on the Curriculum Oversight Team.
Dr. Nangia has served on numerous hospital committees including Chair of Quality Council, Pharmacy, and Ethics. He has been a clinical preceptor for the University of Texas Arlington Nurse Practitioner Program, a Problem-Based Learning Instructor for medical students at University of California, San Diego (UCSD), and taught the Clinical Examination and Reasoning Course at Medical College of Wisconsin. He has completed a basic science research fellowship at UCSD and Scripps Research Institute with publications in both Transplantation and American Journal of Kidney Disease.
Dr. Nangia is a member of the American Board of Internal Medicine Nephrology Board. He has served on the Practicing Nephrology Advisory Group (PNAG) within the American Society of Nephrology (ASN). As a member of PNAG, he has been awarded Faculty of ASN and been involved in several ASN educational activities including writing questions for the Kidney Self-Assessment Program. Dr. Nangia also serves on the RPA Education Committee and is the Co-Creator and Co-Course Director of National Nephrology Business Leadership program for Nephrology Fellows. He is also the co-Creator and co-Host of an FM radio show and podcast, “Doc Talk Live,” aimed at creating health awareness in the Dallas – Fort Worth area. Also, he is a joint venture partner with US Renal Care and Fresenius Medical Care Dialysis Clinics and Medical Director of Acute Inpatient Dialysis for several hospitals.
Dr. Nangia received his undergraduate degree in chemical engineering from the University of Minnesota followed by employment at ExxonMobil prior to entering medical school. He completed his internal medicine training at the Medical College of Wisconsin followed by a research fellowship at the University of California, San Diego in nephrology. He is a Certified Physician Executive and recently completed a coaching fellowship in pursuit of being a certified physician development coach.
As of September 2019, Dr. Nangia reported the following external relationships:
Dr. Nangia serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Joint Venture Partner FMC & USRC in 10 Dialysis Units in Dallas Area.
- Inpatient Dialysis DFW Mid-Cities for FMC (five hospitals) serving as a Medical Director, compensation goes to nephrology practice.
- Co-creator and co-host of Medical Radio Show Doc Talk Live (doctalklive.com) on 104.9 FM/Yupp TV with more than 200 physician guests, funded by Health Care Organization and receiving no compensation.
- Co-Creator & co-host of Medical Radio Show Doc Talk Live (doctalklive.com) on 104.9 FM/Yupp TV with over 200 physician guests. Funded by Health Care Organization and receiving no compensation.
- Co-creator & co-Course Director of Nephrology Business Leadership University (NBLU) - Course that is designed for Nephrology Fellows from various programs across the US. Funded by US Renal Care and receiving no compensation.
- Assistant Clinical Professor of Medicine at University of California San Diego serving as a Voluntary faculty for nephrology fellows.
- ACO Methodist Board of Directors, serving as part of the physician oversight team for ACO; voluntary position.
- Renal Physician Association, Education Committee Member, without compensation.
Dr. Nangia also reported that he is part-owner of Liberty Research.
Matthew Sparks, MD
Dr. Sparks is an assistant professor of medicine at Duke University, a staff physician at the Durham VA Health System, and serves as the Associate Program Director for the Nephrology Fellowship Program. He is Director of Medical Student Research in the Department of Medicine. He is board certified in Nephrology.
His research interest is in the pathogenesis of hypertension, chronic kidney disease, and pulmonary hypertension. His research has been funded by the US Department of Veterans Affairs and the American Heart Association. He is also interested in leveraging social media for medical education.
He is a founding faculty member and program director of the Nephrology Social Media Collective (NSMC) Internship and member of the Board of Directors of Nephrology Journal Club (NephJC), a non-profit organization dedicated to enhancing free online medical education in nephrology. He is co-creator of NephMadness. Faculty lead of Renal Fellow Network. He is a member of several national committees spanning ASN and AHA. He also serves as Education Director for KIDNEYcon- a yearly hands-on conference dedicated to advances in nephrology held in Little Rock, AR each April.
Dr. Sparks received his medical degree from University of Arkansas for Medical Sciences College of Medicine and completed his residency there. He completed his fellowship in nephrology at Duke University School of Medicine.
As of September 2019, Dr. Sparks reported the following external relationships:
Work as an author or editor for following company, with compensation as listed:
- Elsevier, receiving compensation as an editor for Nephrology Secrets.
Dr. Sparks serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Nephrology, Media and Communications Committee; Kidney 360 Editorial Board; without compensation.
- American Heart Association, Kidney in Cardiovascular Disease Leadership Committee; Kidney in Cardiovascular Disease Membership and Communications Committee; Kidney in Cardiovascular Disease SKIL (Education) Committee; without compensation.
- American Journal of Kidney Diseases, Editorial Board Member, without compensation.
- National Kidney Foundation, North Carolina Medical Advisory Board; Kidney Medicine Editorial Board; without compensation.
- Nephrology Journal Club, Board of Directors, without compensation.
Dr. Sparks also reported that he is the associate program director of the Duke University Nephrology Fellowship Program.